Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia.

Link to article at PubMed

Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia.

Clin Microbiol Infect. 2011 Dec 28;

Authors: Teh B, Grayson ML, Johnson PD, Charles PG

Abstract
Clin Microbiol Infect ABSTRACT: We assessed the comparative efficacy of empirical therapy with beta-lactam plus macrolide vs. beta-lactam plus doxycycline for the treatment of community-acquired pneumonia (CAP) among patients in the Australian Community-Acquired Pneumonia Study. Both regimens demonstrated similar outcomes against CAP due to either 'atypical' (Chlamydophila, Legionella or Mycoplasma spp.) or typical bacterial pathogens.

PMID: 22284533 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published.